AnalystsSara NikSara Nik's Stock Forecasts
AnalystsSara Nik
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#5168 out of 5549 analysts
Average Return
-16.66%
Win Rate
24%4 out of 17
Risk vs Reward
Poor
Good
Sara Nik's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +257.06% | $62.00 | $221.38 | 2025-08-08 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +140.58% | $90.50 | $217.71 | 2025-09-26 - 2025-11-14 | Buy |
Cidara Therapeutics IncCDTX | +110.92% | $103.22 | $217.71 | 2025-10-21 - 2025-11-14 | Buy |
Cidara Therapeutics IncCDTX | +96.56% | $110.76 | $217.71 | 2025-10-09 - 2025-11-14 | Buy |
Sara Nik Analyst Color
Get additional color on Sara Nik's coverage of popular stocks
Sara Nik's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eikon Therapeutics IncEIKN | 1 | Buy | $23.00 | +329.91% | Initiates Coverage On | 14 days ago |
Moleculin Biotech IncMBRX | 5 | Buy | $60.00 | +588.07% | Maintains | 2 months ago |
Curis IncCRIS | 3 | Buy | $43.00 | +7,746.72% | Reiterates | 2 months ago |
Pasithea Therapeutics CorpKTTA | 3 | Buy | $3.00 | +710.81% | Reiterates | 4 months ago |
Tvardi Therapeutics IncTVRD | 1 | Buy | $9.00 | +942.87% | Initiates Coverage On | 5 months ago |
Cidara Therapeutics IncCDTX | 5 | Hold | N/A | N/A | Downgrades | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.